Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001047469-18-005006
Filing Date
2018-07-12
Accepted
2018-07-12 16:30:37
Documents
6
Effectiveness Date
2018-07-12

Document Format Files

Seq Description Document Type Size
1 S-3ASR a2236188zs-3asr.htm S-3ASR 316957
2 EX-5.1 a2236188zex-5_1.htm EX-5.1 29884
3 EX-23.2 a2236188zex-23_2.htm EX-23.2 2553
4 G203469.JPG g203469.jpg GRAPHIC 33384
5 G85507.JPG g85507.jpg GRAPHIC 12559
6 G970489.JPG g970489.jpg GRAPHIC 52186
  Complete submission text file 0001047469-18-005006.txt   486136
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-226147 | Film No.: 18950750
SIC: 2836 Biological Products, (No Diagnostic Substances)